-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
E. MERCK AG - DARMSTADT GERMANY
Veröffentlicht in Analytical chemistry (Washington)
VolltextArtikel -
11
-
12
-
13
-
14
Balancing Myocardial Ischemic and Bleeding Risks in Patients With Non-ST-Segment Elevation Myocardial Infarction † † Conflicts of interest: Dr. Cohen has received grant and research support from Sanofi-Aventis, Paris, France; Merck & Company, Whitehouse Station, New Jersey; Datascope Corporation, Montvale, New Jersey; Bayer AG, Leverkeusen, Germany; AstraZeneca, Wilmington, Delaware; COR Therapeutics, Inc., San Francisco, California; Pfizer, Inc., New York, New York; and Guidant Corporation, Ind
Veröffentlicht in The American journal of cardiology
VolltextArtikel -
15
-
16
-
17
-
18
-
19
-
20